Neuroprotection by mitochondria-targeted metformin
US10576093B2 · kind B2 · utility
0Cited by
0References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 26, 2018 |
| Grant date | Mar 3, 2020 |
| Priority date | — |
| Expiry date | Apr 26, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4425
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides modified metformin compounds, particularly mito-metformin compounds, and pharmaceutical compositions thereof. Methods of using the compounds to provide neuroprotection and in the treatment and/or prevention of neurodegenerative diseases are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.